Amarin Announces Two Upcoming Investor Events
October 01 2024 - 8:00AM
Amarin Corporation plc (NASDAQ:AMRN) today announced two important
near-term corporate events:
[I] Third Quarter 2024 Financial Results – October
30 – The Company will report financial results for the
third quarter 2024 on Wednesday, October 30, 2024, immediately
following the close of market trading followed by a conference call
with Amarin’s senior management team at 5:00 pm ET.
Conference Call and Webcast Information:
Access to the live call:Go to the investor relations section of
the Company's website
at www.amarincorp.comDial in within the
United States: 888-506-0062International dial in:
973-528-0011Access Code: 732244
Access to replay: Dial in within the United States:
877-481-4010 International dial in: 919-882-2331Access Code:
51361
A replay of the call will also be available through the
Company's website shortly after the call.
[II] Virtual Analyst & Investor Day 2024 – November
14 – The Company will host a virtual analyst and investor
day on Thursday, November 14, 2024, from 8:00 AM EST to 10:00 AM
EST. The event will be hosted by members of the Amarin senior
management team and will focus on updating the investment community
on the current state of the VASCEPA/VAZKEPA franchise, with
particular attention given to discussions on the dynamics of key
geographies that represent the future value of the franchise,
including Europe. In addition, a dedicated question and answer
session will be held during which the Amarin senior management team
will entertain questions submitted in advance to
investor.relations@amarincorp.com.
As a virtual event, the program will be webcast and archived for
future reference and will be open to all participants;
participation will require a simple registration step before
joining, which will be available through the Company website prior
to this event. Throughout the event, there will be no live
interaction with audience participants.
About AmarinAmarin is an innovative
pharmaceutical company leading a new paradigm in cardiovascular
disease management. Amarin has offices in Bridgewater, New Jersey
in the United States, Dublin in Ireland, Zug in Switzerland, and
other countries in Europe as well as commercial partners and
suppliers around the world. We are committed to increasing the
scientific understanding of the cardiovascular risk that persists
beyond traditional therapies and advancing the treatment of that
risk.
Availability of Other Information About
Amarin Amarin communicates with its investors and the
public using the company website (www.amarincorp.com) and the
investor relations website
(http://www.amarincorp.com/investor-relations), including but not
limited to investor presentations and FAQs, Securities and Exchange
Commission filings, press releases, public conference calls and
webcasts. The information that Amarin posts on these channels and
websites could be deemed to be material information. As a result,
Amarin encourages investors, the media and others interested in
Amarin to review the information that is posted on these channels,
including the investor relations website, on a regular basis. This
list of channels may be updated from time to time on Amarin’s
investor relations website and may include social media channels.
The contents of Amarin’s website or these channels, or any other
website that may be accessed from its website or these channels,
shall not be deemed incorporated by reference in any filing under
the Securities Act of 1933.
Amarin Contact InformationInvestor & Media
Inquiries: Mark Marmur Amarin Corporation plc
PR@amarincorp.comInvestor.relations@amarincorp.com
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Nov 2024 to Dec 2024
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Dec 2023 to Dec 2024
